Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model

Spine

Volumn 33, Issue 8, 2008, Pages 863-869

  Miyazaki, Masashi ^a   Zuk, Patricia A ^a   Zou, Jun ^a   Yoon, Seung Hwan ^a   Wei, Feng ^a   Morishita, Yuichiro ^a   Sintuu, Chananit ^a   Wang, Jeffrey C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adipose tissue; Gene therapy; Mesenchymal stem cells; Rat model; Spine fusion

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; COLLAGEN SPONGE; COMPLEMENTARY DNA; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE REMODELING; CONTROLLED STUDY; EX VIVO STUDY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; NUDE RAT; OSSIFICATION; PALPATION; PRIORITY JOURNAL; RAT; SPINE FUSION;

ADENOVIRIDAE; ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; LUMBAR VERTEBRAE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, NUDE; RECOMBINANT PROTEINS; SPINAL FUSION; STEM CELL TRANSPLANTATION; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 42149139129     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31816b45c3     Document Type: Article

References (28)

1. Boden SD. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 2002;27:S26-S31.
2. Silber JS, Anderson DG, Daffner SD, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003;28:134-9.
3. Ahlmann E, Patzakis M, Roidis N, et al. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002;84-A:716-20.
4. Gupta MC, Maitra S. Bone grafts and bone morphogenetic proteins in spine fusion. Cell Tissue Bank 2002;3:255-67.
5. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
6. Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006;31:2534-9.
7. Kanayama M, Hashimoto T, Shigenobu K, et al. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine 2006;31:1067-74.
8. Vaccaro AR, Anderson DG, Patel T, et al. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 2005;30:2709 -16.
9. Vaccaro AR, Patel T, Fischgrund J, et al. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2005;14:623-9.
10. Perri B, Cooper M, Lauryssen C, et al. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: adiscectomy and fusion: a case study. Spine J 2007;7:235-9.
11. Peterson B, Iglesias R, Zhang J, et al. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine 2005;30:283-9.
12. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28.
13. Dragoo JL, Lieberman JR, Lee RS, et al. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg 2005;115:1665-73.
14. Yang S, Wei D, Wang D, et al. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 2003;18:705-15.
15. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-64.
16. Williams JT, Southerland SS, Souza J, et al. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999;65:22-6.
17. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 1999;96:14482-6.
18. Nakahara H, Dennis JE, Bruder SP, et al. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 1991;195:492-503.
19. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-8.
20. De Ugarte DA, Ashjian PH, Elbarbary A, et al. Future of fat as raw material for tissue regeneration. Ann Plast Surg 2003;50:215-9.
21. Morizono K, De Ugarte DA, Zhu M, et al. Multilineage cells from adipose tissue as gene delivery vehicles. Hum Gene Ther 2003;14:59-66.
22. Holliger EH, Trawick RH, Boden SD, et al. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials-rhBMP-2 and autograft. J Spinal Disord 1996;9:125-8.
23. Kon T, Yamazaki M, Tagawa M, et al. Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 1997;60:291-6.
24. Zhu W, Rawlins BA, Boachie-Adjei O, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 2004;19:2021-32.
25. Riew KD, Wright NM, Cheng S, et al. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 1998;63:357-60.
26. Feeley BT, Conduah AH, Sugiyama O, et al. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res 2006;24:1709-21.
27. Mack CA, Song WR, Carpenter H, et al. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum Gene Ther 1997;8:99-109.
28. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994;91:4407-11.